CRIS Current Research Information System

CAPELLARI, SABINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.262
AS - Asia 12.416
EU - Europa 10.461
SA - Sud America 801
AF - Africa 648
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 4
Totale 38.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.030
SG - Singapore 3.366
VN - Vietnam 3.146
CN - Cina 2.985
IT - Italia 2.407
GB - Regno Unito 2.304
DE - Germania 1.627
HK - Hong Kong 938
SE - Svezia 744
NL - Olanda 708
FR - Francia 605
BR - Brasile 583
IN - India 551
RU - Federazione Russa 458
UA - Ucraina 386
IE - Irlanda 341
BD - Bangladesh 296
KR - Corea 294
FI - Finlandia 215
JP - Giappone 205
CI - Costa d'Avorio 177
ZA - Sudafrica 171
SC - Seychelles 138
CA - Canada 134
EE - Estonia 132
AT - Austria 103
ID - Indonesia 96
JO - Giordania 90
PH - Filippine 83
TG - Togo 81
AR - Argentina 78
MX - Messico 70
BG - Bulgaria 67
CH - Svizzera 57
TH - Thailandia 53
BE - Belgio 52
ES - Italia 50
IQ - Iraq 49
PL - Polonia 43
TR - Turchia 40
UZ - Uzbekistan 34
CO - Colombia 32
TW - Taiwan 32
EC - Ecuador 31
AU - Australia 29
GR - Grecia 29
SA - Arabia Saudita 26
DK - Danimarca 24
PK - Pakistan 19
VE - Venezuela 19
LT - Lituania 17
MY - Malesia 16
PY - Paraguay 16
RO - Romania 16
HR - Croazia 14
IR - Iran 14
NG - Nigeria 14
PE - Perù 14
CL - Cile 13
CZ - Repubblica Ceca 12
TN - Tunisia 12
IL - Israele 11
LB - Libano 11
MA - Marocco 11
AE - Emirati Arabi Uniti 8
HU - Ungheria 8
MD - Moldavia 8
EG - Egitto 7
NO - Norvegia 7
UY - Uruguay 7
JM - Giamaica 6
KE - Kenya 6
SY - Repubblica araba siriana 6
AL - Albania 5
DZ - Algeria 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
SN - Senegal 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
KZ - Kazakistan 4
SR - Suriname 4
AO - Angola 3
GT - Guatemala 3
KH - Cambogia 3
LV - Lettonia 3
LY - Libia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
Totale 38.575
Salva come PNG Salva come JPEG
Città #
Singapore 2.333
Southend 1.983
Ashburn 1.486
Fairfield 1.187
Houston 1.011
Chandler 935
Hong Kong 882
Dong Ket 630
San Jose 615
Ho Chi Minh City 602
Hefei 600
Ann Arbor 594
Woodbridge 589
Seattle 579
Wilmington 526
Bologna 522
Hanoi 513
Cambridge 451
Frankfurt am Main 423
Princeton 409
Santa Clara 367
Beijing 365
Dublin 341
Eygelshoven 338
Boardman 323
Dallas 274
Seoul 254
Lauterbourg 237
Jacksonville 227
Los Angeles 223
Council Bluffs 217
Tokyo 182
Abidjan 177
New York 177
Nanjing 166
Westminster 162
Helsinki 151
Redmond 148
Milan 140
Turin 138
Berlin 128
Padova 127
Munich 122
Buffalo 115
Florence 96
Redondo Beach 96
Da Nang 90
Amman 89
Lomé 81
Jinan 80
São Paulo 80
Shenyang 79
Haiphong 75
Saint Petersburg 74
San Diego 74
Bengaluru 69
Sofia 64
Vienna 63
Shanghai 62
Guangzhou 61
Changsha 60
Tianjin 58
Rome 57
Hebei 55
Medford 54
Nuremberg 54
London 52
Nanchang 52
Des Moines 51
Brussels 50
Jakarta 50
Lappeenranta 49
Chicago 48
Mülheim 44
Montreal 42
Phoenix 41
Olalla 39
Amsterdam 37
Toronto 37
Verona 35
San Francisco 32
Yubileyny 32
Zhengzhou 32
Orem 31
Can Tho 30
Falls Church 30
Jiaxing 30
Warsaw 30
Dearborn 28
Imola 28
Mexico City 28
Hangzhou 27
Hải Dương 27
Redwood City 26
Bern 25
Haikou 25
Naples 25
Mahé 24
Norwalk 24
Atlanta 23
Totale 24.724
Salva come PNG Salva come JPEG
Nome #
A new potential biomarker for dementia with Lewy bodies 912
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding 574
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 519
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 358
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 354
Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-β-hydroxylase deficiency 315
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 298
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 296
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 287
Messenger RNA processing is altered in autosomal dominant leukodystrophy 280
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 269
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 262
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 252
Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD) 251
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 245
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 244
A case of fatal familial insomnia in Africa. 243
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 237
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population 236
Abnormal in vivo cerebral energy metabolism in Huntington’s disease: preliminary findings 234
Benign tremulous parkinsonism in a patient with dardarin mutation. 230
Binary transformation of sequencing data to explore functional genetic patterns. 227
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 226
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 225
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 225
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 223
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 223
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 222
The RET51/FKBP52 complex and its involvement in Parkinson disease. 219
Color choice preference in cognitively impaired patients: A look inside alzheimer’s disease through the use of lüscher color diagnostic 219
Human figure drawing distinguishes Alzheimer’s patients: a cognitive screening test study 216
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 214
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 211
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 211
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 209
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 209
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 208
Age at onset in genetic prion disease and the design of preventive clinical trials 206
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients 206
Alterazione del metabolismo energetico cerebrale in vivo nella malattia di Huntington: dati preliminari 204
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 204
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 204
Lack of association between five serotonin metabolism-related genes and medication overuse headache 200
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 200
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. 200
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 200
Arylsulphatase A activity in familial parkinsonism: a pathogenetic role? 197
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 196
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 195
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 195
A new national survey of centers for cognitive disorders and dementias in Italy 192
Quantifying prion disease penetrance using large population control cohorts 191
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 191
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 190
Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer’s Disease 189
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 189
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 187
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 186
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 186
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 186
Multimodal investigation of melanopsin retinal ganglion cells in Alzheimer's disease 185
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 185
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 185
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 182
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 182
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients 180
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 176
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 176
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 174
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 173
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 173
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 173
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 173
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 172
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 172
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 172
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 171
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 171
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 171
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 168
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 167
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 167
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 166
Observing movement disorders: best practice proposal in the use of video recording in clinical practice 166
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients 166
The Degree of Cardiovascular Autonomic Dysfunction is not Different in GBA-Related and Idiopathic Parkinson's Disease Patients: A Case-Control Instrumental Evaluation 165
Neurosyphilis orofacial dyskinesia: the candy sign. 165
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 164
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 164
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 163
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 163
Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study 162
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 161
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 161
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 161
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 161
Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients 160
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 159
Nuclear lamins: Functions and clinical implications 158
Fragile X premutation tremor/ataxia syndrome (FXTAS): a case with characteristic clinical and MR features. 158
Totale 21.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.191 0 0 0 0 0 0 0 0 0 0 0 1.191
2021/20224.007 386 138 246 212 350 187 87 418 186 382 797 618
2022/20234.230 444 549 192 544 313 298 155 279 708 110 403 235
2023/20241.268 84 182 107 137 109 172 79 110 43 107 75 63
2024/20255.185 239 750 411 362 671 280 468 186 158 452 225 983
2025/202614.177 969 1.328 1.329 1.050 1.451 1.059 1.806 450 2.398 1.073 746 518
Totale 39.350